Site Search

Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... less likely to stay up to date with preventive care if the provision mandating 100% coverage was repealed, resulting in a patient out-of-pocket cost for these services. Fifty-three percent put the dollar amount that would present a barrier to accessing preventive services at less than $200. ...

... cancer. Prostate cancer rates for Black men are 70% higher than the rates for White men. What does the PSA Screening for HIM Act do? Screening can help find prostate cancer at an early stage often before any signs or symptoms are present and before the disease becomes more advanced and more difficult treat. However, out of pocket costs can be a barrier to accessing screening. The five-year survival rate for men diagnosed in early, local or regional stages is around ... for HIM) Act would require health insurance providers to cover prostate-specific antigen (PSA) blood tests for the highest risk patients at no cost.   Throughout this document men refers to individuals assigned male at birth and/or persons with a prostate. Wolf, A. M., Wender, R. C., ...

This ACS CAN chartbook provides cancer-specific data related to Medicare, including basic information about the program, a discussion of its components, ... is for the entire population, not just the Medicare population. x  Id . xi  Reddy SR, Broder MS, Chang E, Paydar C, Chung KC, Kansal AR. Cost of cancer management by stage at diagnosis among Medicare beneficiaries. Curr Med Res Opin . 2022 Aug;38(8):1285-1294. doi: ...

The American Cancer Society Cancer Action Network (ACS CAN) believes everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of income, race, gender identity, sexual orientation, disability status, or where they live. From preventive screening and early detection, through ... with cancer. Clinical trials are also a key part of research and enable the development of better drugs and treatments for cancer. However, cost is often a barrier to enrollment because trial participants are frequently responsible for non-medical costs such as transportation and ...